To access this element change to forms mode OFF
Grant Award View - GA201483
Tau - A diagnostic and therapeutic target in Alzheimer's Disease
GA ID:
GA201483
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
10-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$1,408,239.67
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Tau - A diagnostic and therapeutic target in Alzheimer's Disease
Purpose:
Toxic forms of ‘tau’ protein in the brain are part of the cause of Alzheimer’s disease. This condition is difficult to diagnose, and there are no treatments to stop progression. My research focuses on developing a blood test measuring the levels of toxic tau in patients attending Australian memory clinics. The program will also undertake a world-first clinical trial of an oral drug (SAMe) that targets the tau protein to understand whether this can slow the progression of Alzheimer’s disease.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2009843
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA